In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody
about
Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide ReceptorEmerging targets in lipid-based therapySphingosine 1-Phosphate Receptors: Do They Have a Therapeutic Potential in Cardiac Fibrosis?Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond.Novel selective allosteric and bitopic ligands for the S1P(3) receptor.Sphingosine 1-phosphate receptor 2 (S1P2) attenuates reactive oxygen species formation and inhibits cell death: implications for otoprotective therapyThe prevalence, maintenance, and relevance of G protein-coupled receptor oligomerizationNew paradigms in GPCR drug discovery.Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.Deciphering the GPER/GPR30-agonist and antagonists interactions using molecular modeling studies, molecular dynamics, and docking simulations.Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1.Shear stress induces Gαq/11 activation independently of G protein-coupled receptor activation in endothelial cells.S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis.Identification of a pepducin acting as S1P3 receptor antagonist.Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.The opposing forces of shear flow and sphingosine-1-phosphate control marginal zone B cell shuttling.
P2860
Q27678197-C92F6613-D2A0-45B1-8E47-03F06E63ABBCQ28655456-8EB09A01-B8DC-46F1-97C0-C7F42A493B98Q33753317-8EB20807-FF3A-42B6-A306-AFAA53AFA3BFQ34025135-FF10866E-9CDA-407F-8A96-6C67C455F12EQ34364844-998613A6-E75D-4ABE-91C3-0AADAFF60FC5Q36484486-208DCCC7-7222-4E44-B5D3-D4EE02CB9C7FQ36799651-FEDBD2BA-0C88-4358-A227-DF6F228B23C8Q36935273-2647CCBD-BDFA-43C2-AB5E-2B905C539836Q37140411-DD22330F-754F-434F-8BEA-4FBA52D58403Q39433833-8E32249C-2562-4F0B-8880-126703B3F310Q41583985-896331AB-712D-4778-9EAA-00D2E2F2620AQ41702445-11A28AB2-7B5A-4A51-9EC3-D08B60E9F999Q45956238-7FA4981E-6DD0-4B7A-AB06-9692FE073318Q46315054-EF45B692-5EFC-4362-92D8-1381DC0FD717Q46549922-100D168A-0BB1-4312-98F4-C210F1F0A117Q47141836-B0AB3F9B-8B31-4248-934E-309886671D15Q48353956-3B5F78CB-0789-4445-9FA2-19B49E42509E
P2860
In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@ast
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@en
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@nl
type
label
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@ast
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@en
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@nl
prefLabel
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@ast
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@en
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@nl
P2093
P2860
P3181
P1433
P1476
In vitro and in vivo antagonis ...... l blocking monoclonal antibody
@en
P2093
Greg B Brulte
Greg L Harris
Michael B Creason
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0035129
P407
P50
P577
2012-01-01T00:00:00Z